Specific yeast cell wall mannoprotein (MP40), naturally present in wines, with the unique property of inhibiting potassium bitartrate crystallization. Patent n°2726284.
MANNOSTAB™ LIQUIDE 200 is a targeted enological treatment, based on the inhibition of potassium bitartrate crystallization.
It provides a natural, simple solution to the stability requirements of filtered or non-filtered wines.
• A natural constituent already present in wines, MANNOSTAB™ LIQUIDE 200 perfectly conserves the quality of the wine.
• Involving no waste materials, no energy or water consumption, MANNOSTAB™ LIQUIDE 200 is a responsible treatment which complies with new environmental constraints.
DOSAGE:
The average dosages (between 50 and 150 mL/hL) are determined by stability tests in order to prevent any risks of overdose. Two stability tests can be implemented:
• The cold test, easy to implement in wineries.
• The mini-contact test, realised in laboratory (DIT, Stabilab® – Patent Eurodia)
USA Regulation 27 CFR 24.246 Specific TTB Limitation: 0.2 L/hL
